243. Режим доступа: https://www.uab.edu/medicine/diabetes/faculty/faculty-bios/117-barbara-a-gower.
244. S. J. Athinarayanan, R. N. Adams, S. J. Hallberg, A. L. McKenzie1, N. H. Bhanpuri, W. W. Campbell, J. S. Volek, S. D. Phinney, J. P. McCarter, “Long-Term Effects of a Novel Continuous Remote Care Intervention Including Nutritional Ketosis for the Management of Type 2 Diabetes: A 2-Year Non-randomized Clinical Trial”,
245. T. Salomón, C. Sibbersen, J. Hansen, D. Britz, M. V. Svart, T. S. Voss, N. Møller, N. Gregersen, K. A. Jørgensen, J. Palmfeldt, T. B. Poulsen, M. Johannsen, “Ketone Body Acetoacetate Buffers Methylglyoxal via a Non-enzymatic Conversion during Diabetic and Dietary Ketosis”,
246. S. Hallberg, O. Hamdy, “Before You Spend $26,000 on Weight-Loss Surgery, Do This”,
247. A. B. Evert, M. Dennison, C. D. Gardner, W. T. Garvey, K. H. Karen Lau, J. MacLeod, J. Mitri, R. F. Pereira, K. Rawlings, S. Robinson, L. Saslow, S. Uelmen, P. B. Urbanski, W. S. Yancy Jr, “Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report”,
248. M. Bittman, “Is Alzheimer’s Type 3 Diabetes?”,
249. Там же.
250. D. Thompson, “Alzheimer’s risk factors study calls out obesity in midlife”,
251. M. A. Schilling, “Unraveling Alzheimer’s: Making Sense of the Relationship between Diabetes and Alzheimer’s Disease”,
252. Y. Zhu, B. J. Pandya, H. K. Choi, “Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007–2008”,
253. Shelley,
254. F. L. Santos, S. S. Esteves, A. da Costa Pereira, W. S. Yancy Jr, J. P. L. Nunes, “Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors”,
255. E. Goldberg, Yun-Hee Youm, K. Nguyen, E. Alnemri, V. Dixit, “Ketone body beta-hydroxy butyrate deactivates NLRP3 inflammasome in myeloid cells”,
256. J. R. Biesiekierski, E. D. Newnham, P. M. Irving, J. S. Barrett, M. Haines, J. D. Doecke, S. J. Shepherd, J. G. Muir, P. R. Gibson, “Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial”,
257.
258. J. R. Biesiekierski, S. L. Peterr, E. D. Newnham, O. Rosella, J. G. Muir, P. R. Gibson, “No Effects of Gluten in Patients With Self-Reported Non-Celiac Gluten Sensitivity After Dietary Reduction of Fermentable, Poorly Absorbed, Short-Chain Carbohydrates”, no. 2, 2013: 320–328.
259.
260. Low FODMAP Diet, Stanford Health Care. Режим доступа: https://stanfordhealthcare.org/medical-treatments/l/low-fodmap-diet.html.
261. C-J. Tsai, M. F. Leitzmann, W. C. Willett, E. L. Giovannucci, “Dietary carbohydrates and glycaemic load and the incidence of symptomatic gall stone disease in men”,
262. R. A. Liddle, R. B. Goldstein, J. Saxton, “Gallstone formation during weight-reduction dieting”,
263. D. Festi, A. Colecchia, M. Orsini, A. Sangermano, S. Sottili, P. Simoni, G. Mazzella, N. Villanova, F. Bazzoli, D. Lapenna, M. L. Petroni, S. Pavesi, M. Neri, E. Roda, “Gallbladder motility and gallstone formation in obese patients following very low calorie diets. Use it (fat) to lose it (well)”,
264. J. K. Dyson, Q. M. Anstee, S. McPherson, “Non-alcoholic fatty liver disease: a practical approach to treatment”,
265. P. Paschos, K. Paletas, “Non alcoholic fatty liver disease and metabolic syndrome”,